Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Rudolph

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Opinion on Emerging Drugs|July 2, 2005
Emerging therapies for heart failureAmy E Rudolph, Ellen G McMahon
Molecular and Cellular Endocrinology|May 12, 2004
Aldosterone target organ protection by eplerenoneAmy E Rudolph, Ricardo Rocha, Ellen G McMahon
Journal of Comparative Effectiveness Research|June 22, 2021
To replicate or not to replicate? Insights and interpretations from a randomized trial duplication initiativeMelvin Skip Olson, Kristijan H Kahler, Amy E Rudolph
Mini Reviews in Medicinal Chemistry|August 17, 2005
Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenoneXiao Hu, Suzhen Li, Ellen G McMahon, et al.
Thrombosis and Haemostasis|November 13, 2002
The role of the factor X activation peptide: a deletion mutagenesis approachAmy E Rudolph, Michael P Mullane, Rhonda Porche-Sorbet, et al.
Current Medical Research and Opinion|June 17, 2008
Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care studyJoAnne M Foody, Amie T Joyce, Amy E Rudolph, et al.
Clinical Therapeutics|March 18, 2008
Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United StatesJoAnne M Foody, Amie T Joyce, Amy E Rudolph, et al.
Science (New York, N.Y.)|April 27, 2002
Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vectorB Joseph Hinnebusch, Amy E Rudolph, Peter Cherepanov, et al.
Current Medical Research and Opinion|February 11, 2011
Progression to type 2 diabetes, healthcare utilization, and cost among pre-diabetic patients with or without comorbid hypertensionBruce H Francis, Xue Song, L M Andrews, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 30, 2013
Lessons learned from a survey of the diagnosis and treatment journeys of postmenopausal women with hypertensionLynne Doner Lotenberg, Lisa C Clough, Thomas A Mackey, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Opinion on Emerging Drugs|July 2, 2005
Emerging therapies for heart failureAmy E Rudolph, Ellen G McMahon
Molecular and Cellular Endocrinology|May 12, 2004
Aldosterone target organ protection by eplerenoneAmy E Rudolph, Ricardo Rocha, Ellen G McMahon
Journal of Comparative Effectiveness Research|June 22, 2021
To replicate or not to replicate? Insights and interpretations from a randomized trial duplication initiativeMelvin Skip Olson, Kristijan H Kahler, Amy E Rudolph
Mini Reviews in Medicinal Chemistry|August 17, 2005
Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenoneXiao Hu, Suzhen Li, Ellen G McMahon, et al.
Thrombosis and Haemostasis|November 13, 2002
The role of the factor X activation peptide: a deletion mutagenesis approachAmy E Rudolph, Michael P Mullane, Rhonda Porche-Sorbet, et al.
Current Medical Research and Opinion|June 17, 2008
Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care studyJoAnne M Foody, Amie T Joyce, Amy E Rudolph, et al.
Clinical Therapeutics|March 18, 2008
Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United StatesJoAnne M Foody, Amie T Joyce, Amy E Rudolph, et al.
Science (New York, N.Y.)|April 27, 2002
Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vectorB Joseph Hinnebusch, Amy E Rudolph, Peter Cherepanov, et al.
Current Medical Research and Opinion|February 11, 2011
Progression to type 2 diabetes, healthcare utilization, and cost among pre-diabetic patients with or without comorbid hypertensionBruce H Francis, Xue Song, L M Andrews, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 30, 2013
Lessons learned from a survey of the diagnosis and treatment journeys of postmenopausal women with hypertensionLynne Doner Lotenberg, Lisa C Clough, Thomas A Mackey, et al.
Pageof 3